Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-15-065328
Filing Date
2015-11-13
Accepted
2015-11-13 16:05:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 v424621_s3.htm S-3 266555
2 EXHIBIT 5.1 v424621_ex5-1.htm EX-5.1 16509
3 EXHIBIT 23.1 v424621_ex23-1.htm EX-23.1 3630
4 GRAPHIC tex23-1_logo.jpg GRAPHIC 4241
5 GRAPHIC tlogo.jpg GRAPHIC 26493
  Complete submission text file 0001144204-15-065328.txt   330485
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-208004 | Film No.: 151229176
SIC: 2836 Biological Products, (No Diagnostic Substances)